Presenting Companies at Charité Partnering

  • Amedrix GmbH, Esslingen: Based on a matrix consisting of type I collagen the company Amedrix GmbH develops and produces acellular implants (classified as medical device) for various applications in the human and veterinary sector.
  • AmyloCure, Berlin: Small molecule therapeutics/diagnostics for Alzheimer and Huntington.
  • Caprotec Bioanalytics GmbH, Berlin: We provide access to a superior technology for analyzing small molecule protein interactions e.g. to reduce adverse drug side effects.
  • Cell Medica Limited, London/UK: Pathogenspecific Immunreconstitution in immunocompromised patients.
  • CRP GmbH i.P., Berlin: CRP adsorber for myocardial infarction and stroke therapy.
  • GHC Global Health Care GmbH, Berlin: Technology and service for a telemedical emergency service for airplanes.
  • Humedics GmbH, Grossbeeren: We produce the LiMAxTM / FLIP TM system which is the first device exclusively designed for the real-time assessment of liver function in the exhaled gas flow.
  • ILIAS-medical GmbH, Bochum: Mobile, artificial lung, ECMO System
  • KINAXO Biotechnologies GmbH, Martinsried: Quantitative analysis of the cellular phosphoproteome to support the development of targeted cancer drugs and companion diagnostics.
  • Kirsen Medical Technologies (KMT), Berkeley/ USA: KMT is the leader in Non-Contact Vital Signs Monitoring targeting the $2.4B market with Sleep Diagnostics as initial focus application.
  • Medicyte GmbH, Heidelberg: Medicyte is a life science company, seeking further financing in order to leverage the full therapeutic and non-therapeutic potential of its novel high end primary cell products.
  • Microstim, Luebeck: Development of a tissue and function preserving myostimulator for muscle powered cardiac assistance.
  • Natural Dental Implants AG, Berlin, Early-stage dental technology and services company, making a 100% customized all-ceramic tooth replica, including an anatomically shaped root portion to osseointegrate or to regenerate the periodontal membrane.
  • NeMoDevices AG, Kilchberg/Switzerland: NeMoDevices develops new neuromonitoring systems to optimize diagnosis and treatment of patients with stroke and brain injuries.
  • NonWoTecc Medical GmbH, Köln: Novel biomimetic vascular prostheses.
  • OrganOx Limited, Oxford/UK: A novel medical device for improving the quality and increasing the quantity of organs for transplantation.
  • Particular GmbH, Hannover: Particular produces and employs nanoparticles for biomedicine (implant coatings, nanomarkers)
    using a new, non-chemical process that stands for large material variety and high purity.
  • PluriSelelect GmbH, Leipzig: The pluriSelect develops, produces and sales cell separation technology.
  • Parelectrics, Berlin: Device for noninvasive skin-cancer diagnostics with the ability to.
  • Provecs Medical GmbH, Hamburg: We provide a unique validated platform of combinatorial immunotherapeutics that targets cellular networks in the immune system and delivers products for oncology, vaccines and anti-inflammatories.
  • Scaffion, Berlin: Development of protein-interactions for the treatment of chronic heart failure.
  • Scopis, Berlin: Scopis and markets measuring for different applications of minimal invasive surgery. The systems are based on specially development measuring sheaths, which upgrade conventional endoscopes toprecise laser measurement.
  • SP Solution Pool GmbH, Berlin: Clinical Navigation Systems.
  • Zedira GmbH, Darmstadt: Development of a celiac diesease drug until Phase IIa (PoC).

Members of the Jury

Michael Brandkamp

Stephan Gutzeit

Uwe Maschek

Joachim Rautter

Jens Schneider-Mergener

Klaus Stöckemann

Marco Zeller

Among the investors and institutions supporting entrepreneurs in the Summit were:

Investors attending the Summit

  • Aescap Venture Management B.V., Amsterdam
  • ARCH Venture Partners, San Francisco
  • BayTech Venture Capital Beratungs GmbH
  • B. Braun Melsungen AG, Melsungen
  • Berlin Partner GmbH, Berlin
  • Business Angels Network Deutschland, BAND, Essen
  • Charité Beteiligungsfonds, Berlin
  • Dr. Walter Rust, Business Angel, Berlin
  • Dr. Bernd Wegener, Business Angel, Hennigsdorf
  • Earlybird, Hamburg
  • EXTOREL Private Equity Advisers, Munich
  • Filarete Investimenti Spa (Seed Capital), Milan
  • Freie Universitaet Berlin, profund, Berlin
  • Gazelle Growth Fund, Copenhagen
  • GB Unternehmensentwicklung, Charité - Universitaetsmedizin, Berlin
  • GO:Incubator, Potsdam
  • HealthCap, Stockholm
  • High-Tech Gruenderfonds, Bonn
  • HUMBOLDT-INNOVATION GmbH, Berlin
  • IBB Beteiligungsgesellschaft mbH, Berlin
  • Investitionsbank Berlin
  • InVivo Biotech Services GmbH, Hennigsdorf
  • JStone Innovation Management srl, Torino
  • Lodestone IP, London
  • Max-Planck-Innovation GmbH, Munich
  • Medical Research Council Technology Fund, London
  • Novartis Pharma Deutschland, Berlin
  • PEPPERMINT. Financial Partners, Berlin
  • Pfizer Europe, Berlin
  • Pfizer Oncologie Europe
  • Philips Healthcare Incubator, Eindhoven
  • Projekttraeger Juelich, Berlin
  • Proteus Venture Partners, Palo Alto
  • Royal Society Enterprise Development Fund, London
  • Seventure Partners, Paris
  • Sofinnova, Paris
  • Sopep, Koeln
  • Technische Universitaet Berlin Gruendungsservice, Berlin
  • Technologie Transfer, Charité - Universitaetsmedizin, Berlin
  • TVM Capital GmbH, Munich
  • Ventech, Paris
  • VESALIUS BIOCAPITAL, Luxemburg
  • Wellcome Trust, London
  • Wellington Partners, Munich